Chemical biology of type IV secretion systems

IV型分泌系统的化学生物学

• 批准号: 10569670
• 负责人: Carrie Shaffer
• 金额: $ 26.79万
• 依托单位: UNIVERSITY OF KENTUCKY
• 依托单位国家: 美国
• 财政年份: 2020
• 资助国家: 美国
• 起止时间: 2020-03-01 至 2025-01-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10569670
• 关键词: 2-hydroxypyridine; Acceleration; Address; Antibiotic Resistance; Bacteria; Bacterial Genome; Basic Science; Biochemical; Biogenesis; Biological; Biological Assay; Biology; C10; Cells; Cellular biology; Centers of Research Excellence; Chemicals; Clinical; Collaborations; Complement; Complex; DNA; Destinations; Development; Discipline; Engineering; Epithelial Cells; Escherichia coli; Eukaryotic Cell; Exhibits; Faculty; Fostering; Foundations; Genetic; Goals; Helicobacter pylori; Impairment; Infection; Infectious Diseases Research; Knowledge; Lead; Libraries; Ligand Binding; Lipids; Lipopolysaccharide Biosynthesis Pathway; Mechanics; Mediating; Medical; Microscopy; Molecular; Molecular Machines; Molecular Probes; Nucleic Acids; Nucleoproteins; Oncoproteins; Organic Synthesis; Outcome; Pathogenesis; Pathogenicity Island; Peptidoglycan; Pharmaceutical Chemistry; Pharmacologic Substance; Phenotype; Pilum; Plant Model; Play; Polysaccharides; Prokaryotic Cells; Proteins; Regulation; Research; Research Design; Resolution; Resources; Rhizobium radiobacter; Risk; Role; Series; Signal Pathway; Stomach; Stomach Diseases; Structure-Activity Relationship; System; Systems Biology; Therapeutic; Toxin; Type IV Secretion System Pathway; Validation; Virulence; Work; antimicrobial; appendage; carcinogenicity; cell envelope; design; extracellular; genetic approach; high throughput screening; inhibitor; innovation; insight; interdisciplinary approach; malignant stomach neoplasm; microbial; microbiome; model development; mutant; nanomachine; novel; pathogen; pathogenic bacteria; pharmacophore; protein complex; rational design; repository; response; scaffold; scale up; screening; small molecule; system architecture; tool; tumorigenic; virtual screening

PROJECT SUMMARY Bacteria have evolved specialized nanomachines to deliver microbial cargo across the cell envelope. One versatile translocation apparatus, the type IV secretion system (T4SS), can be strategically deployed to inject macromolecular substrates into target bacterial or eukaryotic recipient cells. Despite their importance in bacterial pathogenesis and dissemination of antibiotic resistance determinants, the mechanisms by which the T4SS assembles and transports payload remain largely undefined. To address this knowledge gap, the long-term goal of this proposal is to develop and apply robust molecular tools to accelerate fundamental studies of T4SS nanomachines. The cag T4SS of the gastric bacterium Helicobacter pylori has emerged as an important system for understanding how a single molecular machine can transport diverse cargo into target cells. Whereas some T4SS have the capacity to secrete hundreds of proteins or DNA-protein complexes into the host cell, the ability to translocate a diverse repertoire of lipid, nucleic acid, protein, and polysaccharide substrates distinguishes the cag T4SS from other systems. Notably, the bacterial oncoprotein CagA is rapidly delivered to host gastric cells via cag T4SS mechanisms. Translocated H. pylori effector molecules activate innate defenses and dysregulate signaling pathways that influence progression of gastric disease; consequently, colonization by cag T4SS- positive H. pylori significantly augments the risk for gastric cancer. As a result of its central role in bacterial pathogenesis, the T4SS represents an ideal target for antimicrobials. In this application, we propose to identify and mechanistically characterize novel small molecule-based T4SS modulators. Iterative structure-activity relationship studies will be used to develop chemical scaffolds and pharmacophores with optimized anti-virulence potential. Probe development will take advantage of expertise and assay platforms in the Shaffer lab and will leverage synergistic resources in the proposed CPRI Computational Core (ligand-binding model development, rational design, virtual screening), CPRI Translational Core (high throughput assay support, novel compound repositories, and ADMET profiling), and the Organic Synthesis Core (medicinal chemistry and scale-up). Prioritized and validated chemical probes will be used in conjunction with biochemical and genetic approaches to interrogate cag T4SS regulation and dynamic steps in substrate translocation. Using a similar multidisciplinary approach, we will determine how the H. pylori cag T4SS apparatus assembles at the bacteria-host cell interface. Collectively, these studies will stimulate new basic research directions and will provide important insight into how the T4SS nanomachine orchestrates the delivery of specific molecular cargo to target cells to drive microbial pathogenesis. Furthermore, this work will generate powerful chemical tools that are broadly applicable to infectious disease research, and will identify potent lead compounds with the potential to disarm T4SS function in a variety of medically-relevant pathogens.

项目摘要 细菌已经进化出专门的纳米机器来运送微生物货物穿过细胞包膜。一 多功能易位装置，IV型分泌系统（T4 SS），可以战略性地部署注射 大分子底物进入靶细菌或真核受体细胞。尽管它们在细菌中的重要性 抗生素耐药决定因素的发病机制和传播，T4 SS的机制， 组装和运输有效载荷在很大程度上仍不明确。为了解决这一知识差距，长期目标是 该提案的一个重要目的是开发和应用强大的分子工具，以加速T4 SS的基础研究 纳米机器胃细菌幽门螺杆菌的cag T4 SS已经成为一个重要的系统 以了解单个分子机器如何将不同的货物运输到靶细胞中。而一些 T4 SS具有向宿主细胞分泌数百种蛋白质或DNA-蛋白质复合物的能力， 转运脂质、核酸、蛋白质和多糖底物的多样性， T4 SS从其他系统。值得注意的是，细菌癌蛋白CagA被迅速递送到宿主胃细胞 通过CAG T4 SS机制。易位H.幽门螺杆菌效应分子激活先天防御和失调 影响胃病进展的信号通路;因此，cag T4 SS- 阳性H.幽门螺杆菌显著增加胃癌的风险。由于其在细菌中的核心作用， T4 SS是抗微生物药物的理想靶点。在本申请中，我们提出识别 和机械表征新的基于小分子的T4 SS调节剂。迭代构效关系 关系研究将用于开发具有优化的抗毒性的化学支架和药效团 潜力探针开发将利用Shaffer实验室的专业知识和分析平台， 在拟议的CPRI计算核心（配体结合模型开发， 合理设计，虚拟筛选），CPRI翻译核心（高通量分析支持，新化合物 储存库和ADMET分析），以及有机合成核心（药物化学和放大）。 优先和验证的化学探针将与生物化学和遗传学方法结合使用 探讨cag T4 SS的调节和底物转运的动态步骤。使用类似的多学科 方法，我们将确定如何H。pylori cag T4 SS装置在细菌-宿主细胞界面组装。 总的来说，这些研究将刺激新的基础研究方向，并将提供重要的见解，如何 T4 SS纳米机器协调特定分子货物到靶细胞的递送，以驱动微生物 发病机制此外，这项工作将产生强大的化学工具，广泛适用于 传染病研究，并将确定潜在的潜在解除T4 SS功能的有效先导化合物 多种医学相关病原体中。